← Eichor
Condition: Pharmacologic Action Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pharmacologic Action

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness
Phase 1 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06796361Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Phase 2 · 2 location(s) · North Florida Foundation for Research and Education · NCT04460872The Effectiveness and Safety of Pharmacopuncture on Inpatients With Acute Knee Pain Caused by Traffic Accidents
NA · 1 location(s) · Jaseng Medical Foundation · NCT06931951Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanom
Phase 1 · 2 location(s) · Yana Najjar · NCT04572451Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resi
Phase 2 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT06511908A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not H
Phase 3 · 248 location(s) · Pfizer · NCT06679140A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compar
Phase 3 · 22 location(s) · Grifols Therapeutics LLC · NCT07555483Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Phase 2/Phase 3 · 17 location(s) · University of Melbourne · NCT05105633Abatacept for the Treatment of Giant Cell Arteritis
Phase 3 · 9 location(s) · University of Pennsylvania · NCT04474847Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Phase 4 · 8 location(s) · Sunnybrook Health Sciences Centre · NCT04289142Natural History of Depression, Bipolar Disorder and Suicide Risk
Phase N/A · 1 location(s) · National Institute of Mental Health (NIMH) · NCT06462196Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO
NA · 1 location(s) · Fondazione Ricerca e Innovazione Cardiovascolare ETS · NCT06535568Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor
Phase 2 · 15 location(s) · Genelux Corporation · NCT06463665A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Phase 1/Phase 2 · 81 location(s) · Novartis Pharmaceuticals · NCT04104776
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.